A Phase 1 Clinical Study of SIPS-2209-1 Compared to SIPS-2209-2 and SIPS2209-3 in Healthy Korean Volunteers
Status:
Completed
Trial end date:
2022-09-21
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to evaluate of bioequivalence between fixed-dose
combination and co-administration of the individual components under fasting conditions in
healthy Korean volunteers.